Meanwhile, as SAA1 was knocked down or overexpressed in ovarian cancer cells, the ELISA results further confirmed that SAA1 in the cell supernatants was also decreased or increased with it (Fig. 2G-H). This evidence concerns the gene SAA1 and ovarian cancer.